Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nolvadex Breast Cancer Prevention Registry Should Be Developed - Cmte.

Executive Summary

FDA should work with Zeneca to develop a Nolvadex (tamoxifen) registry system to track healthy women who are taking the drug to reduce their risk of developing breast cancer, FDA's Oncologic Drugs Advisory Committee recommended Sept. 2.

You may also be interested in...

FDA GI Division Director Justice Is Returning To FDA From Genentech

Genentech Senior Clinical Scientist Robert Justice, MD, is returning to FDA as director of the Division of Gastrointestinal & Coagulation Drug Products in September

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts